Innate Pharma S.A. (EPA:IPH)
1.560
+0.014 (0.91%)
Jun 27, 2025, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €153.35 million as of June 27, 2025. Its market cap has decreased by -8.04% in one year.
Market Cap
153.35M
Enterprise Value
103.58M
Revenue
20.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.56
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 153.35M, an increase of 19,259.51%. That is a compound annual growth rate of 32.60%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EssilorLuxottica Société anonyme | 109.85B |
Sanofi | 100.21B |
Sartorius Stedim Biotech | 19.39B |
bioMérieux | 14.21B |
Eurofins Scientific SE | 10.85B |
Ipsen | 8.49B |
Virbac | 2.72B |
emeis Société anonyme | 1.82B |